Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biohaven Pharmaceuticals
Pharma
Pfizer pays $60M to resolve Biohaven's Nurtec kickback claims
Pfizer—which bought Biohaven in 2022—is commiting more than $59.7 million to resolve kickback allegations tied to migraine med Nurtec.
Fraiser Kansteiner
Jan 27, 2025 10:39am
Pfizer to press pause on large M&A deals, CEO says
Jun 11, 2024 10:50am
Pfizer makes Lady Gaga the star of Nurtec ODT migraine push
Jun 14, 2023 10:18am
With a tepid recommendation, NICE signs off on Pfizer's Vydura
May 31, 2023 10:25am
The top 10 pharma drug brand ad spenders for 2022
May 1, 2023 3:00am
Takeda, Biohaven, Astellas—Fierce Pharma Asia
Mar 24, 2023 8:45am
